Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
KFSHRC Performs Over 5,000 Successful Kidney Transplants
-
Transactions in connection with share buyback programme
-
Sportradar Secures Major Client Wins on Strength of Managed Trading Services
-
Arlanda express signs exclusive framework agreement with ZetaDisplay for digital signage solutions
-
Offentliggørelse af prospekt, Investeringsforeningen Wealth Invest
-
Ændring af emissionstillæg i Investeringsforeningen Nykredit Invest
-
Preliminary data on early redemptions (prepayments)
-
Leading Financial Markets Lawyer Ciarán McGonagle Joins Tokenovate as Chief Legal and Product Officer
-
Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked Loan
-
Yara Clean Ammonia, Scatec, ECHEM and MOPCO signs Heads of Terms for renewable ammonia offtake agreement in Egypt
-
Notification on the transaction concluded by manager in issuer's securities
-
Ole Vesterbæk resigns as CFO of Green Hydrogen Systems
-
Press Release - Update on Summer bookings
-
Capgemini reinforces its automotive systems engineering capabilities in Germany with the acquisition of Lösch & Partner
-
Composition of Kalmar Corporation’s Shareholders’ Nomination Board
-
Voltalia and Taqa Arabia pursue the development of the cluster combining renewable energy generation with green hydrogen production in Egypt
-
Exor Press Release - Periodic Report on the Buyback Program
-
FDA Approves PYZCHIVA® (ustekinumab-ttwe), Samsung Bioepis’ Biosimilar to Stelara
-
Alm. Brand A/S - Alm. Brand enters into agreement with Norwegian insurer Gard on divestment of Energy & Marine business for DKK 1.6 billion
-
Caledonia declares quarterly dividend
-
Bedford Metals Completes Satellite Survey at Ubiquity Lake Uranium Project
-
Decisions of the organising meeting of the Board of Directors of Kalmar
-
GHO Capital realises significant return with sale of FairJourney Biologics
-
Groupe Casino sells over €200M of real estate assets to Tikehau Capital
-
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA
-
TGS and PGS – Last Day of Trading in PGS Shares
-
EUR 1.535 billion share buyback completed
-
-
LIfT BioSciences appoints Antonin (Tony) de Fougerolles as Chairman of its Board of Directors
-
Total voting rights
-
Voting Rights and Capital
-
Total Voting Rights and Capital
-
Share repurchase programme
-
Mesoblast to File Biologics License Application for Ryoncil® FDA Approval Next Week
-
Wendel joins Providence to support Globeducate, a leading international K-12 education group, through its next phase of growth
-
Sword Group: Acquisitions in the UK
-
Kalmar’s financial information in 2024
-
Atlas Luxco S.à r.l., a subsidiary of Atlas Investissement S.A.S., announces public offers to purchase all of the outstanding common shares and SDRs of Millicom International Cellular S.A. for USD 24
-
Kalmar specifies its outlook for 2024
-
Multitude SE: Repurchase of own shares 28.06.2024
-
EMGS reports prefunding for multi-client acquisition in Norway
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Sampo plc’s share buybacks 28 June 2024
-
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’
-
Start of Day Message
-
Idorsia’s JERAYGO (aprocitentan) approved in Europe as first and only ERA for the treatment of resistant hypertension
-
FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US
-
Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ®
-
Corbion reports the progress of its € 20 million share buyback program 24 June – 28 June 2024
